Yukun Cui

发表

Androgen receptor overexpression induces tamoxifen resistance in human breast cancer cells

S. Hilsenbeck, S. Fuqua, S. Andò, 2010, Breast Cancer Research and Treatment.

The c-Yes 3′-UTR contains adenine/uridine-rich elements that bind AUF1 and HuR involved in mRNA decay in breast cancer cells

S. Fuqua, G. Brewer, Yukun Cui, 2005, The Journal of Steroid Biochemistry and Molecular Biology.

Forkhead box C1 boosts triple‐negative breast cancer metastasis through activating the transcription of chemokine receptor‐4

Yukun Cui, H. Pan, Zhilan Peng, 2018, Cancer science.

Hydrogen-Rich Medium Regulates Cr(VI)-Induced ER Stress and Autophagy Signaling in DF-1 Cells

Jianzhu Liu, Yukun Cui, Kangping Liu, 2021, Biological Trace Element Research.

Interaction of the retinoblastoma gene product, RB, with cyclophilin A negatively affects cyclosporin‐inhibited NFAT signaling

R. Chiu, K. Yokoyama, Yukun Cui, 2002, Journal of cellular biochemistry.

TOP1 inhibition induces bifurcated JNK/MYC signaling that dictates cancer cell sensitivity

Hisashi Tanaka, A. Giuliano, X. Cui, 2022, International journal of biological sciences.

Targeting fatty acid synthase sensitizes human nasopharyngeal carcinoma cells to radiation via downregulating frizzled class receptor 10

Jianting Zhang, Yukun Cui, Wenhe Huang, 2020, Cancer biology & medicine.

Insights into the role of progesterone receptors in breast cancer.

Adrian V. Lee, C. Osborne, S. Fuqua, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Streptococcus agalactiae-induced autophagy of bovine mammary epithelial cell via PI3K/AKT/mTOR pathway

Jianzhu Liu, Yukun Cui, B. Han, 2022, Journal of Dairy Research.

Targeting the estrogen receptor in clinical breast cancer.

S. Fuqua, Yukun Cui, 2002, Breast disease.

Identification of triptonide as a therapeutic agent for triple negative breast cancer treatment

A. Giuliano, X. Cui, J. Hao, 2021, Scientific Reports.

Regulation of Parkin in Cr (VI)-induced mitophagy in chicken hepatocytes.

Jianzhu Liu, Yukun Cui, Pimiao Zheng, 2022, Ecotoxicology and environmental safety.

A hypersensitive estrogen receptor α mutation that alters dynamic protein interactions

S. Fuqua, Yukun Cui, M. H. Herynk, 2010, Breast Cancer Research and Treatment.

Breast cancer lung metastasis: Molecular biology and therapeutic implications

A. Giuliano, X. Cui, Yukun Cui, 2018, Cancer biology & therapy.

A symbiotic bacterium of Antarctic fish reveals environmental adaptability mechanisms and biosynthetic potential towards antibacterial and cytotoxic activities

Liangbiao Chen, Zhizhen Zhang, Rulong Liu, 2023, Frontiers in Microbiology.

FOXC1 is a Critical Mediator of EGFR Function in Human Basal-like Breast Cancer

B. Karlan, A. Giuliano, S. Orsulic, 2014, Annals of Surgical Oncology.

Synergistic inhibition of MEK and reciprocal feedback networks for targeted intervention in malignancy

Yukun Cui, Yanan Li, Qingrong Dong, 2019, Cancer biology & medicine.

Elevated Expression of MAPK Phosphatase 3 in Breast Tumors—A Mechanism of Tamoxifen Resistance

S. Hilsenbeck, S. Fuqua, R. Nicholson, 2006 .

Elevated expression of mitogen-activated protein kinase phosphatase 3 in breast tumors: a mechanism of tamoxifen resistance.

S. Hilsenbeck, S. Fuqua, R. Nicholson, 2006, Cancer research.

Breast Cancer Patients with Progesterone Receptor PR-A-Rich Tumors Have Poorer Disease-Free Survival Rates

Susan G. Hilsenbeck, Heidi L. Weiss, Torsten A. Hopp, 2004, Clinical Cancer Research.

Estrogen and progesterone receptor isoforms: clinical significance in breast cancer

S. Fuqua, Yukun Cui, 2004, Breast Cancer Research and Treatment.

A New Compound with Increased Antitumor Activity by Cotargeting MEK and Pim-1

Xiaomin Song, Yukun Cui, Ying Cheng, 2020, iScience.

Low Levels of Estrogen Receptor β Protein Predict Resistance to Tamoxifen Therapy in Breast Cancer

Heidi L. Weiss, Torsten A. Hopp, Yukun Cui, 2004, Clinical Cancer Research.

Growth factor-induced resistance to tamoxifen is associated with a mutation of estrogen receptor α and its phosphorylation at serine 305

S. Fuqua, C. Giordano, I. Barone, 2009, Breast Cancer Research and Treatment.

Mechanisms of Resistance to Hormone Therapy

S. Fuqua, Yukun Cui, 2006 .

Phosphorylation of Estrogen Receptor α Blocks Its Acetylation and Regulates Estrogen Sensitivity

Yukun Cui, S. Fuqua, R. Pestell, 2004, Cancer Research.

Cooperative action of tamoxifen and c-Src inhibition in preventing the growth of estrogen receptor–positive human breast cancer cells

S. Fuqua, H. Weiss, Yukun Cui, 2006, Molecular Cancer Therapeutics.

Elevated FKBP52 expression indicates a poor outcome in patients with breast cancer

X. Cui, Yukun Cui, Fan Zhang, 2017, Oncology letters.

Metastasis-associated protein 2 is a repressor of estrogen receptor alpha whose overexpression leads to estrogen-independent growth of human breast cancer cells.

S. Fuqua, Rakesh Kumar, R. Pestell, 2006, Molecular endocrinology.

Expression of the K303R estrogen receptor-alpha breast cancer mutation induces resistance to an aromatase inhibitor via addiction to the PI3K/Akt kinase pathway.

S. Fuqua, C. Giordano, I. Barone, 2009, Cancer research.

Phosphorylation of estrogen receptor alpha blocks its acetylation and regulates estrogen sensitivity.

Wade V Welshons, Yukun Cui, S. Fuqua, 2004, Cancer research.

Association between the Estrogen Receptor α A908G Mutation and Outcomes in Invasive Breast Cancer

S. Hilsenbeck, S. Fuqua, Meng-Fen Wu, 2007, Clinical Cancer Research.

Hormone Action and Clinical Significance of the Estrogen Receptor α.

S. Fuqua, Yukun Cui, J. Selever, 2009, Cancer treatment and research.

Label-free detection of breast cancer cells using a functionalized tilted fiber grating.

H. Qu, Xuehao Hu, Yukun Cui, 2022, Biomedical optics express.

Phosphorylation of the Mutant K303R Estrogen Receptor α at Serine 305 Impacts Aromatase Inhibitor Sensitivity

S. Fuqua, I. Barone, S. Andò, 2009, Oncogene.

Evaluating the expression of heat shock protein 27 and topoisomerase II α in a retrospective cohort of patients diagnosed with locally advanced breast cancer and treated with neoadjuvant anthracycline-based chemotherapies

Yue Xu, Yukun Cui, Wenhe Huang, 2023, Frontiers in oncology.